Human Metabolome Technologies, Inc. (TYO:6090)
Japan · Delayed Price · Currency is JPY 600.00
-23.00 (-3.69%)
Jun 4, 2026, 3:30 PM JST
TYO:6090 Income Statement
Financials in millions JPY. Fiscal year is July - June.
Millions JPY. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 1,296 | 1,455 | 1,345 | 1,299 | 1,223 | 1,124 | |
Revenue Growth (YoY) | -13.37% | 8.18% | 3.54% | 6.21% | 8.81% | 0.54% |
Cost of Revenue | 521 | 533 | 476 | 440 | 384 | 318 |
Gross Profit | 775 | 922 | 869 | 859 | 839 | 806 |
Selling, General & Admin | 485 | 487 | 459 | 454 | 486 | 663 |
Research & Development | 177 | 177 | 181 | 185 | 158 | 98 |
Operating Expenses | 670 | 672 | 649 | 648 | 648 | 766 |
Operating Income | 105 | 250 | 220 | 211 | 191 | 40 |
Interest Expense | -1 | -2 | -2 | -2 | -2 | -1 |
Interest & Investment Income | 2 | - | - | - | - | - |
Currency Exchange Gain (Loss) | 1 | -9 | 5 | 4 | 46 | 4 |
Other Non Operating Income (Expenses) | 1 | 2 | 17 | 20 | 18 | 17 |
EBT Excluding Unusual Items | 108 | 241 | 240 | 233 | 253 | 60 |
Gain (Loss) on Sale of Investments | -7 | -7 | - | - | - | -23 |
Other Unusual Items | 27 | 35 | 21 | 4 | 9 | 14 |
Pretax Income | 128 | 269 | 261 | 237 | 262 | 51 |
Income Tax Expense | 11 | 13 | 18 | -48 | -5 | -7 |
Net Income | 117 | 256 | 243 | 285 | 267 | 58 |
Net Income to Common | 117 | 256 | 243 | 285 | 267 | 58 |
Net Income Growth | -63.32% | 5.35% | -14.74% | 6.74% | 360.35% | - |
Shares Outstanding (Basic) | 6 | 6 | 6 | 6 | 6 | 6 |
Shares Outstanding (Diluted) | 6 | 6 | 6 | 6 | 6 | 6 |
Shares Change (YoY) | -3.96% | -0.69% | 0.14% | 0.08% | -0.05% | 0.70% |
EPS (Basic) | 20.61 | 43.59 | 41.10 | 48.26 | 45.25 | 9.84 |
EPS (Diluted) | 20.61 | 43.59 | 41.10 | 48.26 | 45.25 | 9.84 |
EPS Growth | -61.81% | 6.08% | -14.85% | 6.66% | 360.04% | - |
Free Cash Flow | - | 225 | 203 | 186 | 182 | -60 |
Free Cash Flow Per Share | - | 38.31 | 34.33 | 31.50 | 30.85 | -10.16 |
Dividend Per Share | 15.000 | 15.000 | 15.000 | 10.000 | - | - |
Dividend Growth | - | - | 50.00% | - | - | - |
Gross Margin | 59.80% | 63.37% | 64.61% | 66.13% | 68.60% | 71.71% |
Operating Margin | 8.10% | 17.18% | 16.36% | 16.24% | 15.62% | 3.56% |
Profit Margin | 9.03% | 17.59% | 18.07% | 21.94% | 21.83% | 5.16% |
Free Cash Flow Margin | - | 15.46% | 15.09% | 14.32% | 14.88% | -5.34% |
EBITDA | 220.75 | 353 | 306 | 291 | 255 | 95 |
EBITDA Margin | 17.03% | 24.26% | 22.75% | 22.40% | 20.85% | 8.45% |
D&A For EBITDA | 115.75 | 103 | 86 | 80 | 64 | 55 |
EBIT | 105 | 250 | 220 | 211 | 191 | 40 |
EBIT Margin | 8.10% | 17.18% | 16.36% | 16.24% | 15.62% | 3.56% |
Effective Tax Rate | 8.59% | 4.83% | 6.90% | - | - | - |